Skip to main content

Table 3 Comparison of the median prices of the inhaled and oral generic and originator asthma and COPD medicine brands

From: Access to affordable medicines and diagnostic tests for asthma and COPD in sub Saharan Africa: the Ugandan perspective

Generic brands

Median (IQR) price in UgX

Median (IQR) price in USD

Originator brands

Median (IQR) price in UgX

Median (IQR) price in USD

Salbutamol 100 μg

10,000 (9000–13,000)

2.8 (2.5–3.6)

Ventolin 100 μg

12,000 (10000–15,000)

3.3 (2.8–4.2)

Ipratropium bromide 20 μg

60,000 (48500–65,000)

16.7 (13.5–18.1)

Atrovent 20 μg

62,500 (60000–65,000)

17.4 (16.7–18.1)

Ipratropium 40 μg

64,000 (56750–65,000)

17.8 (15.8–18.1)

Atrovent 40 μg

65,000 (65000–70,000)

18.1 (18.1–19.4)

Salbutamol/ipratropium 100/20 μg

50,000 (35000–65,000)

13.9 (9.7–18.1)

Combivent 100/20 μg

40,000 (30000–50,000)

11.1 (8.3–13.9)

Formoterol-budesonide 4.5/160 μg

80,000 (45000–85,000)

22.2 (12.5–23.6)

Symbicort 4.5/160 μg

100,000 (85000–120,000)

27.8 (23.6–33.3)

Salmeterol-fluticasone propionate 25/125 μg

48,000 (35000–50,000)

13.3 (9.7–13.9)

Seretide 25/125 μg

50,000 (48000–60,000)

13.9 (13.3–16.7)

Budesonide 200 μg

37,500 (33000–42,000)

10.4 (9.2–11.7)

Pulmicort 200 μg

100,000 (75000–130,000)

27.8 (20.8–36.1)

Fluticasone propionate 250 μg

25,000 (25000–26,000)

6.9 (6.9–7.2)

Flixotide 250 μg

87,500 (80000–95,000)

24.3 (22.2–26.4)

Fluticasone propionate 125 μg

27,000 (25000–40,000)

7.5 (6.9–11.1)

Flixotide 125 μg

87,500 (87500–87,500)

24.3 (24.3–24.3)

Fluticasone propionate 50 μg

27,500 (25000–30,000)

7.6 (6.9–8.3)

Flixotide 50 μg)

78,500 (78500–78,500)

21.8 (21.8–21.8)

Tablets montelukast 10 mg

1000 (800–1200)

0.3 (0.2–0.3)

Singular 10 mg

1100 (900–1400)

0.3 (0.3–0.4)

Tablets montelukast 20 mg

1200 (1000–1500)

0.3 (0.3–0.4)

Singular 20 mg

1200 (1100–1500)

0.3 (0.3–0.4)

  1. IQR-Inter-quartile range, UgX-Uganda shillings, USD-US dollars